(NP (NP (NP (DT The) (JJ human) (JJ myelomonocytic) (NN cell) (NN line) (NN U-937)) (PP (IN as) (NP (NP (DT a) (NN model)) (PP (IN for) (S (NP-SBJ (-NONE- *)) (VP (VBG studying) (NP (NP (NNS alterations)) (PP (IN in) (NP (JJ steroid-induced) (NN monokine) (NN gene) (NN expression))))))))) (: :)) (NP (NP (JJ marked) (NN enhancement)) (PP (IN of) (NP (JJ lipopolysaccharide-stimulated) (NN interleukin-1) (NN beta) (NN messenger) (NN RNA) (NNS levels))) (PP (IN by) (NP (NN 1,25-dihydroxyvitamin) (NN D3))) (. .)))
(S (NP-SBJ (NP (DT The) (JJ active) (NN metabolite)) (PP (IN of) (NP (NP (NN vitamin) (NN D)) (, ,) (NP (NP (NN 1,25-dihydroxyvitamin) (NN D3)) (PRN (-LRB- -LCB-) (NP (NN 1,25--LRB-OH-RRB-2D3)) (-RRB- -RCB-)))))) (, ,) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ potent) (NN regulator)) (PP (IN of) (NP (JJ human) (JJ (macrophage monocyte)) (NN function)))) (ADVP (FW in) (FW vitro))) (. .))
(S (S-ADV (NP-SBJ (-NONE- *)) (VP (TO To) (VP (VB establish) (NP (NP (DT a) (NN model)) (PP (IN for) (NP (NP (NN 1,25--LRB-OH-RRB-2D3) (NN regulation)) (PP (IN of) (NP (JJ human) (NN monocyte) (NN monokine) (NN synthesis))))))))) (, ,) (NP-SBJ-320 (NP (CD three) (JJ human) (NN cell) (NNS lines)) (PRN (-LRB- -LRB-) (NP-COOD (NP (NN U-937)) (, ,) (NP (NN THP-1)) (, ,) (CC and) (NP (NN HL-60))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN examined) (NP (-NONE- *-320)) (PP (IN for) (: :) (NP-COOD (NP (LST (LS 1) (-RRB- -RRB-)) (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ functional) (NN 1,25--LRB-OH-RRB-2D3) (NNS receptors)))) (: ;) (NP (LST (LS 2) (-RRB- -RRB-)) (NP (DT the) (NN accumulation)) (PP (IN of) (NP-COOD (NP (NP (NP (NN interleukin-1) (NN beta)) (PRN (-LRB- -LRB-) (NP (NN IL-1) (NN beta)) (-RRB- -RRB-))) (NN mRNA)) (CC and) (NP (NN IL-1) (NN beta) (NN protein)))) (PP (IN in) (NN response) (TO to) (NP (NP (NN lipopolysaccharide)) (PRN (-LRB- -LRB-) (NP (NN LPS)) (-RRB- -RRB-))))) (: ;) (CC and) (NP (LST (LS 3) (-RRB- -RRB-)) (NP (DT the) (NN regulation)) (PP (IN of) (NP (DT this) (NN response))) (PP (IN by) (NP (NN 1,25--LRB-OH-RRB-2D3)))))))) (. .))
(S (NP-SBJ (DT All) (CD three) (NN cell) (NNS lines)) (VP-COOD (VP (VBD expressed) (NP (NN vitamin) (NN D) (NN receptor))) (CC and) (VP (VBD had) (VP (VBN increased) (NP (NP (NNS levels)) (PP (IN of) (NP (NN IL-1) (NN beta) (NN mRNA)))) (PP (IN in) (NN response) (TO to) (NP (NN LPS)))))) (. .))
(S (NP-SBJ (NP (NN Preincubation)) (PP (IN of) (NP (NNS cells))) (PP (IN with) (NP (NN 1,25--LRB-OH-RRB-2D3)))) (VP (VBD augmented) (NP (NN IL-1) (NN beta) (NN mRNA) (NNS levels)) (PP (RB only) (IN in) (NP (NP-COOD (NP (NN U-937)) (CC and) (NP (NN HL-60))) (NNS cells)))) (. .))
(S (UCP-COOD (PP (IN From) (NP (DT these) (NNS data))) (, ,) (CC and) (S-ADV (NP-SBJ (-NONE- *)) (VP (VBG taking) (PP (IN into) (NP (NN consideration))) (NP (PRP$ their) (NP-COOD (NP (NP (NN state)) (PP (IN of) (NP (NN differentiation)))) (CC and) (NP (NP (JJ relative) (NN ease)) (PP (IN of) (NP (NN culture))))))))) (, ,) (NP-SBJ-323 (NN U-937)) (VP (VBD was) (VP (VBN chosen) (NP (-NONE- *-323)) (PP (IN over) (NP-COOD (NP (NN HL-60)) (CC and) (NP (NN THP-1)))) (PP (IN as) (NP (NP (DT the) (NN cell) (NN line)) (SBAR (WHNP-324 (-NONE- 0)) (S (NP-SBJ (PRP we)) (ADVP (RB further)) (VP (VBD characterized) (NP (-NONE- *T*-324))))))))) (. .))
(S (PP (IN In) (NP (NN U-937) (NNS cells))) (, ,) (NP-SBJ-325 (NP (JJ optimum) (NP-COOD (NP (NN time)) (CC and) (NP (NN dose)))) (PP (IN of) (NP (NP (NN pretreatment)) (PP (IN with) (NP (NN 1,25--LRB-OH-RRB-2D3)))))) (VP (VBD were) (VP (VBN determined) (S (NP-SBJ (-NONE- *-325)) (VP (TO to) (VP (VB be) (NP-PRD (QP (CD 12-24)) (NN h)) (PP (IN at) (NP (NP (NP (DT a) (NN receptor) (JJ saturating) (NN concentration)) (PP (IN of) (NP (NN 1,25--LRB-OH-RRB-2D3)))) (PRN (-LRB- -LRB-) (NP (CD 10) (NN nM)) (-RRB- -RRB-))))))))) (. .))
(S (NP-SBJ (NP (NN Preincubation)) (PP (IN of) (NP (NNS cells))) (PP (IN with) (NP (NN 1,25--LRB-OH-RRB-2D3)))) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (DT the) (NN time) (NN course)) (PP (IN of) (NP (NP (NN IL-1) (NN beta) (NN mRNA) (NN appearance)) (PP (IN in) (NN response) (TO to) (NP (NN LPS)))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP-SBJ (NP (NN exposure)) (PP (IN of) (NP (NN U-937) (NNS cells))) (PP (TO to) (NP (NN 1,25--LRB-OH-RRB-2D3)))) (VP-COOD (VP (VBD increased) (PP (IN by) (NP (CD 200) (NN %))) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NP (NN IL-1) (NN beta) (NN mRNA)) (VP (VBD detected) (NP (-NONE- *))))))) (CC and) (VP (VBD decreased) (PP (IN by) (NP (NP (CD three) (NNS orders)) (PP (IN of) (NP (NN magnitude))))) (NP (NP (DT the) (NN concentration)) (PP (IN of) (NP (NN LPS))) (VP (VBN required) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB achieve) (NP (NP (JJ steady) (NN state) (NN mRNA) (NNS levels)) (ADJP (JJ equivalent) (PP (TO to) (NP (NP (DT those)) (VP (VBN observed) (NP (-NONE- *)) (PP (IN in) (NP (NP (NN U-937) (NNS cells)) (VP (RB not) (VBN preincubated) (NP (-NONE- *)) (PP (IN with) (NP (DT the) (NN hormone.2+o)))))))))))))))))))
